Thematic Review Series: Proteomics. Proteomic analysis of lipid-protein complexes

by Tomas Vaisar
Published 2009-05-01

An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide

by Geoffrey D. Wool, Tomas Vaisar, Catherine A. Reardon, Godfrey S. Getz
Published 2009-09-01

Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein

by Timothy J. Sontag, Ronald Carnemolla, Tomas Vaisar, Catherine A. Reardon, Godfrey S. Getz
Published 2012-05-01

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity

by Katya B. Rubinow, Tomas Vaisar, Chongren Tang, Alvin M. Matsumoto, Jay W. Heinecke, Stephanie T. Page
Published 2012-07-01

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S]

by Tomáš Vaisar, Chongren Tang, Ilona Babenko, Patrick Hutchins, Jake Wimberger, Anthony F. Suffredini, Jay W. Heinecke
Published 2015-08-01

Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway[S]

by Nathalie Pamir, Patrick Hutchins, Graziella Ronsein, Tomas Vaisar, Catherine A. Reardon, Godfrey S. Getz, Aldons J. Lusis, Jay W. Heinecke
Published 2016-02-01

Type 2 diabetes is associated with loss of HDL endothelium protective functions.

by Tomáš Vaisar, Erica Couzens, Arnold Hwang, Michael Russell, Carolyn E Barlow, Laura F DeFina, Andrew N Hoofnagle, Francis Kim
Published 2018-01-01

Effect of niacin monotherapy on high density lipoprotein composition and function

by Scott M. Gordon, Marcelo J. Amar, Kianoush Jeiran, Michael Stagliano, Emma Staller, Martin P. Playford, Nehal N. Mehta, Tomas Vaisar, Alan T. Remaley
Published 2020-08-01

Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine

by Bianca Scolaro, Marina S. Nogueira, Aline Paiva, Adriana Bertolami, Lucia P. Barroso, Tomas Vaisar, Sean P. Heffron, Edward A. Fisher, Inar A. Castro
Published 2018-05-01

HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity

by Mark S. Borja, Kit F. Ng, Angela Irwin, Jaekyoung Hong, Xing Wu, Daniel Isquith, Xue-Qiao Zhao, Bryan Prazen, Virginia Gildengorin, Michael N. Oda, Tomáš Vaisar
Published 2015-10-01

Serum amyloid A3 does not contribute to circulating SAA levels

by Tsuyoshi Chiba, Chang Yeop Han, Tomas Vaisar, Kentaro Shimokado, Atil Kargi, Mei-Hsiu Chen, Shari Wang, Thomas O. McDonald, Kevin D. O'Brien, Jay W Heinecke, Alan Chait
Published 2009-07-01

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II

by John T. Melchior, Scott E. Street, Tomas Vaisar, Rachel Hart, Jay Jerome, Zsuzsanna Kuklenyik, Noemie Clouet-Foraison, Carissa Thornock, Shimpi Bedi, Amy S. Shah, Jere P. Segrest, Jay W. Heinecke, W. Sean Davidson
Published 2021-01-01

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity1[S]

by Daniel Seung Kim, Amber A. Burt, Jane E. Ranchalis, Simona Vuletic, Tomas Vaisar, Wan-Fen Li, Elisabeth A. Rosenthal, Weijiang Dong, Jason F. Eintracht, Arno G. Motulsky, John D. Brunzell, John J. Albers, Clement E. Furlong, Gail P. Jarvik
Published 2015-07-01